Genetics

Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds. Together, the flagship ARK Innovation ETF (NYSE: ARKK) and the ARK Genomic Revolution ETF (NYSE: ARKG) bought...

Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began trading on June 17, 2021. The new year saw the company announcing its diversification into drug development. Will this...

This article by Lauren Wilson was originally published on Weedmaps, and appears here with permission. As awareness of cannabinoid hyperemesis syndrome (CHS) expands, both among medical doctors and patients, we are collectively becoming more and more able to identify a condition that has been...

OG DNA Genetics recently disclosed a licensing agreement in conjunction with Green Peak Innovations, a medical cannabis producer and distributor in the Michigan market. This arrangement will concede Green Peak Innovations consent to the DNA brand and access to their genetics portfolio for use at...

The bullish case for Applied Genetic Technologies Corp (NASDAQ: AGTC), a nano-cap biotech conducting human clinical trials of adeno-associated virus-based gene therapies, can be made on the basis of an encouraging pipeline and valuation reasons, according to Wells Fargo. The Analyst Wells Fargo...